
Actively managed fund
Candriam Eqs L Biotech R GBP Cap
- ISIN
- LU1269736911
- Category
- Sector Equity Biotechnology
How good is this fund, really?
See the rating in the appAbout Candriam Eqs L Biotech R GBP Cap
Candriam's Biotechnology fund is an actively managed Luxembourg UCITS sub-fund that buys shares of biotechnology companies around the world. Managers screen firms in two steps, first judging how convincing the available clinical data is, then scoring management quality, growth potential, competitive position, value creation and indebtedness. The NASDAQ Biotechnology Index (Net Return) serves as a reference universe, and while most holdings come from it, outside names are allowed. ESG screening leaves out companies that fall short of recognised international standards. This R share class is sterling-denominated and accumulating. Its key information document shows a risk indicator of 5 of 7, a 6-year holding period and an ongoing charge of 1.13%.
Watch this fund for free Add Candriam Eqs L Biotech R GBP Cap to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.
Watch the fund for freeWhere to buy Candriam Eqs L Biotech R GBP Cap — platforms and fees
Sold on 3 platforms we follow.
-
AJ Bell Annual fee: See the platformGo to AJ Bell ↗
-
Fidelity Annual fee: See the platformGo to Fidelity ↗
-
interactive investor Annual fee: See the platformGo to interactive investor ↗
Candriam Eqs L Biotech R GBP Cap — its category
Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.
Biotechnology funds →Other funds
- ARK Genomic Revolution ETF A USD Acc
- AXA Framlington Biotech Fund - Z Acc
- AXA Framlington Biotech Z Inc
- Biotech Growth Ord
- Candriam Eqs L Biotech I GBP Cap
- First Trust NYSE Arca Biotech ETFAUSDAcc
- Franklin Biotechnology Discv Z(acc)GBP
- Global X Genomics & Biotech ETF USD Acc
- International Biotechnology Ord
- Invesco NASDAQ Biotech ETF
- iShares Nasdaq US Biotech ETF USD Acc
- iShares Nasdaq US Biotech ETF USD Dist